Overview

Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric Surgery

Status:
Recruiting
Trial end date:
2028-05-01
Target enrollment:
0
Participant gender:
All
Summary
The present protocol aims to understand and establish whether there is a causal link between adipose tissue metabolic remodeling and Type 2 Diabetes (T2D) remission after bariatric surgery. All participants will have a bariatric surgery, divided in 2 groups: with or without T2D.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Université de Sherbrooke
Collaborators:
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Treatments:
Niacin
Niacinamide
Nicotinic Acids
Criteria
Inclusion Criteria:

- Aged 18 to 65

- BMI 35 kg/m2

- Diagnosed T2D - according to Diabetes Canada diagnostics criteria.

- Diagnosed non-T2D - according to Diabetes Canada diagnostics criteria.

- Women with a negative serum pregnancy test.

Exclusion Criteria:

- Treatment with an oral contraceptive;

- Treatment with fibrate, thiazolidinedione, insulin, or beta-blocker, drugs that affect
metabolism and cannot be stopped temporarily or which have long-lasting effects;

- Presence of overt cardiovascular disease, liver or renal failure or other uncontrolled
medical conditions;

- Any other contraindication to surgery or to temporarily suspending current medications
for diabetes, lipids or hypertension;

- Smoking or consumption of more than 2 alcoholic beverages per day;

- Any contraindication to MRI;

- A Diabetes Remission (DiaRem) score >8 (low probability of T2D remission);

- Having participated to a research study with exposure to radiation in the last two
years before the start of the study;

- Pregnant or breastfeeding women;

- Patients weighing more than 200 kg to respect the weight and gantry limit of our MRI
and PET/CT scanners.

- Being allergic to eggs